Guest guest Posted September 11, 2003 Report Share Posted September 11, 2003 Hi Elaine and all, Lillie's just gotten new labs - a bit discouraging, as her levels have gone up again. Though we were told to expect a period of adjusting til the levels correct. It seems like her endo is doing the right thing, for the most part, though I'd love to know what you think, as well. Her new numbers are: 9/5/03 T4 free, direct: 1.54 (0.83 - 1.44) TSH: 0.045 (0.360 - 5.800) T3: 172 (91-164) The doctor suggested she go up in dosage again, to 15 mg per day of Methimazole, so that's what she's doing, split 3 a day. (up from 10) So, she started at 30 in May, went down to 20, then down to 10, and now is going up to 15. Is this a normal course of events? Doctor also suggested we get labs again in 6 weeks. Next time I'll ask for the FREE T3! (The lab previous to this one, to recap, was: 8/8/03: T4 free, direct: .86 (0.83 - 1.44) TSH: 0.055 (0.360 - 5.800) T3: 113 (91-164) Her dosage was lowered on 8/11/03, from 20 to 10 mg.) Here's one more question, please: Elaine said, > Having the TSI and TBII is a good way to tell if you have > stimulating and/or blocking TRAb. On the subject of anti-body tests: Would you recommend that everyone ask for these tests who has some eye involvement with GD? Lillie was given the TSI test to confirm her diagnosis, at the beginning in May. Her eyes have improved some, but are still not as they were. The ophthalmologist (who's father has GD!) is not too worried, says she's doing fine. Would it be worthwhile to ask for the TBII or the TRab, as well? I do have trouble sorting all the info, and admire and applaud and thank those of you who can understand it!!! Thank you all for being here, it's a great comfort, Lillie's mom, ************** ******** Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.